Gynecologists are supporting a project currently being studied to provide vaccine recommendations for human papillomavirus (HPV) for boys, the virus responsible for cervical cancer, told AFP their national representative body, FNCGM.
"Universal vaccination (girls and boys aged 11 to 14 years, with a number of children reaching 19 years) will reduce the number of cancers due to HPV, with a greater population coverage," said FNCGM president Dr. Pia de Reilhac, in a statement sent to AFP.
Vaccination is replaced in girls
In France, vaccination is now recommended and replaced for all girls aged 11 to 14 and aged between 15 and 19 years if catching up. Also recommended until the age of 26 in men who have sex with men (MSM) and in patients with depressed immune systems.
According to a draft opinion released on October 30, the High Health Authority (HAS) is considering extending this recommendation to boys, "to curb transmission" of HPV. The health authority has been confiscated by the Minister of Health.
"The medical gynecologist, by (the voice) National Federation of Medical Gynecological Colleges (FNCGM), has provided opinions that strongly support this recommendation," said FNCGM, which corresponds to that "public consultation 'until November 27.'
Cancer is related to papillomavirus
Sexually transmitted infections related to HPV can cause years later cancer in women and men, the cervix, vagina, penis, anus or throat.
Around 1,750 new cases of HPV-related cancer occur annually in France in men, and 4,580 in women. The only cervical cancer still kills 1,100 women each year in France and 900 new cases are diagnosed.
Some countries, such as the United States, have recommended that all teenagers be vaccinated against HPV at age 11 or 12 before being exposed to the risk of this virus.